DEBASISH TRIPATHY to Tamoxifen
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Tamoxifen.
Connection Strength
0.461
-
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. JAMA Oncol. 2020 04 01; 6(4):505-511.
Score: 0.133
-
How long should adjuvant tamoxifen be continued? Oncology (Williston Park). 1994 Oct; 8(10):25-33; discussion 33, 37-8.
Score: 0.091
-
Co-targeting estrogen receptor and HER2 pathways in breast cancer. Breast. 2014 Feb; 23(1):2-9.
Score: 0.085
-
Aromatase inhibitors: rationale and use in breast cancer. Annu Rev Med. 2005; 56:103-16.
Score: 0.046
-
Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study. Cancer. 2004 Sep 01; 101(5):969-72.
Score: 0.045
-
Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner. PLoS One. 2014; 8(6):e62361.
Score: 0.021
-
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res Treat. 1992; 24(2):85-95.
Score: 0.019
-
Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005 Oct; 201(4):586-97.
Score: 0.012
-
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer. J Clin Oncol. 2003 Mar 15; 21(6):999-1006.
Score: 0.010